Robert Dee Etherington - Jul 29, 2024 Form 4 Insider Report for Clene Inc. (CLNN)

Role: Chief Executive Officer, Director
Signature: /s/ Jerry Miraglia POA
Stock symbol: CLNN
Transactions as of: Jul 29, 2024
Transactions value $: $81,960
Form type: 4
Date filed: 7/30/2024, 09:03 AM
Previous filing: Jun 10, 2024
Next filing: Aug 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLNN	Common Stock	Options Exercise	$82K	+27.3K	+965.71%	$3.00^*	30.1K	Jul 29, 2024	Direct	F1
holding	CLNN	Common Stock						636	Jul 29, 2024	By LLC	F2, F3
holding	CLNN	Common Stock						1.25K	Jul 29, 2024	By trust	F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLNN	Stock Options (Right to buy)	Options Exercise	$0	+27.3K		$0.00	27.3K	Jul 29, 2024	Common Stock	27.3K	$3.00	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's ownership in the previously disclosed 56,593 shares of common stock being reduced to 2,829 shares.
F2	On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's stock beneficial ownership in the previously disclosed 12,717 shares of common stock indirectly owned being reduced to 636 shares.
F3	The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.
F4	On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's beneficial ownership in the previously disclosed 25,000 shares of common stock indirectly owned being reduced to 1,250.
F5	The securities are owned by the Etherington Revocable Trust. Mr. Etherington is the co-trustee of the Etherington Revocable Trust. The shares owned by the Etherington Revocable Trust may be deemed to be beneficially owned by Mr. Etherington.
F6	On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's stock option grant of 1,092,777 options to purchase common stock being reduced to 54,639 options. The exercise option price for these options was increased from $0.15 per share to $3.00 per share.